RPG Life Sciences Ltd

RPG Life Sciences Ltd

None%
- close price
About

Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients[1]

Key Points

Business Overview:[1]
RPGLS is a part of the RPG Group. It started as a joint venture with G.D Searle and was renamed when G.D Searle withdrew its India operations. Currently, the group has major listed companies like KEC International, CEAT, Zensar Tech, etc.
RPGLS is an integrated research based pharmaceutical company operating in domestic and international markets in branded formulations, global generics and APIs

  • Market Cap Cr.
  • Current Price
  • High / Low /
  • Stock P/E
  • Book Value
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Industry:

Part of BSE Healthcare BSE Allcap BSE SmallCap

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF
Upcoming result date: tomorrow

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow

Ratios

Figures in Rs. Crores

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.41% 72.62% 72.62% 72.82% 72.82% 72.82% 72.82% 72.82% 72.82% 72.82% 72.95% 72.95%
0.15% 0.08% 0.25% 0.38% 0.33% 0.46% 0.56% 0.90% 1.15% 1.35% 1.30% 1.46%
0.01% 0.03% 0.01% 0.11% 0.27% 1.57% 1.77% 2.16% 2.61% 5.45% 6.06% 6.14%
27.43% 27.27% 27.11% 26.70% 26.58% 25.15% 24.85% 24.12% 23.44% 20.40% 19.70% 19.46%
No. of Shareholders 22,11520,75721,36020,83720,22621,08821,86622,13722,23223,48124,89124,867

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls